Depressive Symptoms and Risk for Sudden Cardiac Death in Stable Coronary Artery Disease

Minna Lahtinen1, Antti M Kiviniemi2, M Juhani Junttila2

  • 1Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland; Research Unit of Nursing Science and Health Management, University of Oulu, Oulu, Finland.

Insights

Depression symptoms significantly increase the risk of sudden cardiac death (SCD) in stable coronary artery disease (CAD) patients. Screening for and treating depression is crucial for managing cardiac risk.

Area of Science:

  • Cardiology
  • Psychiatry
  • Public Health

Background:

  • The link between depression and mortality in stable coronary artery disease (CAD) patients remains unclear.
  • Understanding the specific modes of death associated with depressive symptoms is essential for targeted interventions.

Purpose of the Study:

  • To investigate the association between depressive symptoms and various modes of death, including all-cause mortality, noncardiac death, sudden cardiac death (SCD), and non-SCD.
  • To determine if depressive symptoms predict SCD independently of traditional cardiovascular risk factors.

Main Methods:

  • A cohort of 1,928 patients with angiographically documented CAD were assessed for depressive symptoms using the Depression Scale (DEPS).
  • Patients were stratified into quartiles based on DEPS scores and followed for a median of 6.3 years for mortality outcomes.
  • Statistical analyses, including univariate and multivariate risk assessments, were performed to evaluate the association between DEPS quartiles and different death types.

Main Results:

  • The incidence of SCD increased progressively across DEPS quartiles, with the highest quartile showing a fourfold elevated univariate risk and a 3.2-fold elevated multivariate risk for SCD compared to the lowest quartile.
  • Depressive symptoms were significantly associated with an increased risk of SCD, independent of established clinical risk factors.
  • No significant association was found between DEPS scores and non-SCD or noncardiac deaths.

Conclusions:

  • Depressive symptoms are a significant independent predictor of sudden cardiac death in patients with stable coronary artery disease.
  • These findings underscore the importance of routine depression screening and the implementation of interventions to manage depressive symptoms in CAD patients to potentially reduce SCD risk.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
492
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
283
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
391
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
703
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.7K